Pharmacoeconomics (PE), a sub discipline of health economics, evaluates the behavior of individuals, firms, and markets relevant to the use of pharmaceutical products, services, and programs, and with the focus on the costs (inputs) and consequences (outcomes) of that use. Cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis are the four techniques...